Sensebiotek
AI-enabled electronic-nose systems that analyze human body odors for early health signals and other applications
Highlights
- Young companyFounded 2023
- New on EvolcAdded 2026-11-10
About Sensebiotek
SenseBioTek develops an AI-enabled electronic-nose platform that analyzes volatile compounds emitted by the human body. Its technology combines nanosensor-based detection, SkinVOCs® collection technology and algorithms for decoding odor signatures.
Its primary application is early, non-invasive detection of disease signals, with an initial focus on cancers. Other potential uses include personalized cosmetics and biological-signal analysis; its subsidiary SenseDetect explores environmental, industrial and security-related odors.
Founded in 2023, SenseBioTek is based in Aigremont, France. Its team includes medical, scientific, analytical chemistry and research-and-development roles, and it works with academic and industrial partners.
Product: An AI-enabled electronic-nose platform using nanosensors and volatile-compound analysis to detect signals in human body odors.
Jobs at Sensebiotek
More health & medtech companies
Sensome
Tissue-sensing technology for medical-device manufacturers and physicians performing minimally invasive proceduresNew on EvolcSensyl
Manufactures PC/SC Vitale and CPS smart-card readers for French healthcare professionals and medical facilitiesNew on EvolcSeprodom
Home healthcare services for patients in Réunion, the French Caribbean and MayotteNew on EvolcSeqone
AI-powered genomic analysis software for molecular laboratories conducting clinical sequencing and diagnosticsNew on EvolcRemote-friendlySerein Chez Soi
Home-care and domestic assistance for older, ill and dependent people in ParisNew on EvolcSerenadom
Home-care support for older people and people with disabilities in Paris and Val-de-MarneNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Frontend frameworks
- AstroMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- VueMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.